Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Montgomery

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|December 24, 2014
What to expect from a third step in treatment resistant depression: A prospective open study on escitalopramDaniel Souery, Raffaella Calati, Konstantinos Papageorgiou, et al.
Journal of Affective Disorders|March 23, 2023
Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorderLucie Bartova, Gernot Fugger, Markus Dold, et al.
International Clinical Psychopharmacology|December 2, 2021
Social withdrawal as a trans-diagnostic predictor of short-term remission: a meta-analysis of five clinical cohortsVincenzo Oliva, Giuseppe Fanelli, Siegfried Kasper, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 24, 2018
Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samplesChiara Fabbri, Siegfried Kasper, Alexander Kautzky, et al.
Psychiatric Genetics|February 26, 2025
A machine learning approach to predict treatment efficacy and adverse effects in major depression using CYP2C19 and clinical-environmental predictorsMarco Calabrò, Chiara Fabbri, Alessandro Serretti, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 28, 2024
The clinical perspective on late-onset depression in European real-world treatment settingsLucie Bartova, Gernot Fugger, Markus Dold, et al.
Journal of Affective Disorders|May 17, 2023
Body mass index and clinical outcomes in individuals with major depressive disorder: Findings from the GSRD European Multicenter DatabaseChristoph Kraus, Alexander Kautzky, Victoria Watzal, et al.
Psychiatry Research|June 25, 2025
The impact of depression on functioning: Relation to medication response and other predictorsIlenia White, Antonina Luca, Maria Luca, et al.
Journal of Affective Disorders|March 16, 2021
The Role of Relationship Status in Major Depressive Disorder - Results of the European Group for the Study of Resistant DepressionLucie Bartova, Markus Dold, Gernot Fugger, et al.
European Archives of Psychiatry and Clinical Neuroscience|April 25, 2025
Mild motor signs and depression: more than just medication side effects?Antonina Luca, Maria Luca, Siegfried Kasper, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|December 24, 2014
What to expect from a third step in treatment resistant depression: A prospective open study on escitalopramDaniel Souery, Raffaella Calati, Konstantinos Papageorgiou, et al.
Journal of Affective Disorders|March 23, 2023
Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorderLucie Bartova, Gernot Fugger, Markus Dold, et al.
International Clinical Psychopharmacology|December 2, 2021
Social withdrawal as a trans-diagnostic predictor of short-term remission: a meta-analysis of five clinical cohortsVincenzo Oliva, Giuseppe Fanelli, Siegfried Kasper, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 24, 2018
Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samplesChiara Fabbri, Siegfried Kasper, Alexander Kautzky, et al.
Psychiatric Genetics|February 26, 2025
A machine learning approach to predict treatment efficacy and adverse effects in major depression using CYP2C19 and clinical-environmental predictorsMarco Calabrò, Chiara Fabbri, Alessandro Serretti, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 28, 2024
The clinical perspective on late-onset depression in European real-world treatment settingsLucie Bartova, Gernot Fugger, Markus Dold, et al.
Journal of Affective Disorders|May 17, 2023
Body mass index and clinical outcomes in individuals with major depressive disorder: Findings from the GSRD European Multicenter DatabaseChristoph Kraus, Alexander Kautzky, Victoria Watzal, et al.
Psychiatry Research|June 25, 2025
The impact of depression on functioning: Relation to medication response and other predictorsIlenia White, Antonina Luca, Maria Luca, et al.
Journal of Affective Disorders|March 16, 2021
The Role of Relationship Status in Major Depressive Disorder - Results of the European Group for the Study of Resistant DepressionLucie Bartova, Markus Dold, Gernot Fugger, et al.
European Archives of Psychiatry and Clinical Neuroscience|April 25, 2025
Mild motor signs and depression: more than just medication side effects?Antonina Luca, Maria Luca, Siegfried Kasper, et al.
Pageof 12